Pharma

Trinity Health Mid-Atlantic partnered with mental health software provider Neuroflow last August to mitigate healthcare’s...

Acadia Pharmaceuticals drug Nuplazid failed to win FDA approval for the treatment of psychosis in Alzheimer’s disease...

Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage...

Helping your employees quit vaping increases workplace productivity and reduces the overall impact on your business’s...

By applying a more comprehensive maternity journey, we are able to address social determinants of health that vary by...

Homeward is working to fill in the gap of primary and specialty care in rural areas. Currently working in Michigan, it...

Enhertu, a breast cancer drug from AstraZeneca and Daiichi Sankyo, is now FDA approved for treating patients whose tumors...

Medications that treat opioid use disorder (OUD) — such as methadone, buprenorphine and extended-release naltrexone — are...

The European Commission (EC) has granted approval for Merck (MSD outside the US and Canada) and AstraZeneca’s Lynparza...

For most companies and medtech, in particular, good business practices (GBP) happens on multiple levels. On the micro...

The development of therapeutics for transmissible spongiform encephalopathies (TSEs) continues to be challenged by the...

Amgen has signed a definitive agreement to acquire biopharmaceutical company ChemoCentryx for $52 for each share in cash or...

Better Meds is already removing paper forms and manual processes from NHS Trust’s system

Partnership will accelerate development of oncology medicines and expand presence in China

The diabetic macular oedema (DME) space recently witnessed a new approval; the US Food and Drug Administration (FDA)...